Angiotensin Receptor/Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor Use in Patients With a Left Ventricular Assist Device: A Propensity Score Matched Analysis

Am J Cardiol. 2024 Jan 15:211:180-182. doi: 10.1016/j.amjcard.2023.10.020. Epub 2023 Oct 20.

Authors

Bharat Rawlley¹, Andres Cordova Sanchez², Kartik Gupta³, Matthew Ramm¹, Debanik Chaudhuri⁴

Affiliations

¹ Department of Internal Medicine, State University of New York Upstate Medical University, Syracuse, New York.
² Division of Cardiology, Department of Medicine, University of Vermont Medical Center, Burlington, Vermont.
³ Division of Cardiovascular Diseases, Henry Ford Hospital, Detroit, Michigan.
⁴ Department of Internal Medicine, State University of New York Upstate Medical University, Syracuse, New York. Electronic address: [email protected].

PMID: 37866448
DOI: 10.1016/j.amjcard.2023.10.020

No abstract available

Keywords: angiotensin-converting enzyme inhibitors; heart failure; sacubitril-valsartan; ventricular assist devices.

MeSH terms

Aminobutyrates / pharmacology
Angiotensin Receptor Antagonists / pharmacology
Angiotensin Receptor Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Drug Combinations
Heart Failure*
Heart-Assist Devices*
Humans
Neprilysin
Propensity Score
Receptors, Angiotensin
Stroke Volume
Tetrazoles
Valsartan

Substances

Angiotensin-Converting Enzyme Inhibitors
Neprilysin
Valsartan
Receptors, Angiotensin
Aminobutyrates
Angiotensin Receptor Antagonists
Drug Combinations
Tetrazoles